Published inAthelasAt-Home Monitoring for Chemotherapy | Part 2 — Clinical Literature ReviewPart 2 — Clinical Literature ReviewSep 8, 2020Sep 8, 2020
Published inAthelasAt-Home Monitoring for Chemotherapy | The Future TodayExpedited Time-to-Treatment & Dose-Adjustment by Athelas Finger-StickAug 10, 2020Aug 10, 2020
Stars Manage to Outcomes, not TasksUnderstanding Personal “Fit” in High-Performance StartupsJun 15, 2020Jun 15, 2020
Idea Inclusion & Team ThinkingUnderstanding Personal “Fit” in High-Performance StartupsJun 8, 2020Jun 8, 2020
Scale as an Input, Not an OutputUnderstanding Personal “Fit” in High-Performance StartupsJun 1, 2020Jun 1, 2020
The Golden Rule, Momentum is TrustUnderstanding Personal “Fit” in High-Performance StartupsMay 26, 2020May 26, 2020
Published inThe StartupInside PG&E | What I Learned Pitching California’s Biggest ThreatWhen a culture of risk aversion creates the risk of harmNov 5, 2019Nov 5, 2019
Inside PG&E | What I learned PitchingWhen a culture of risk aversion creates risk of harmOct 31, 2019Oct 31, 2019
Published inStartup GrindScaling AI + IoT Hardware: A Growth HackPeople are bad at knowing what they want in new product. So how, then, do we scale expensive and long-lead hardware solutions for new…Sep 28, 2017Sep 28, 2017
Published inStartups.comScaling A.I. Hardware: A Hedge PlayPeople are bad at knowing what they want in new product. So how, then, do we scale expensive and long-lead hardware solutions for new…May 31, 2017May 31, 2017